Compare CSV & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | PHAR |
|---|---|---|
| Founded | 1991 | 1988 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 678.1M | 1.1B |
| IPO Year | 1996 | N/A |
| Metric | CSV | PHAR |
|---|---|---|
| Price | $42.13 | $17.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $59.00 | $38.00 |
| AVG Volume (30 Days) | ★ 74.0K | 27.2K |
| Earning Date | 02-25-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ 3.09 | 0.00 |
| Revenue | ★ $409,658,000.00 | $362,274,000.00 |
| Revenue This Year | $3.81 | $25.19 |
| Revenue Next Year | $3.37 | $4.47 |
| P/E Ratio | ★ $13.68 | $3,085.37 |
| Revenue Growth | 1.07 | ★ 26.78 |
| 52 Week Low | $35.51 | $7.50 |
| 52 Week High | $49.41 | $18.30 |
| Indicator | CSV | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 46.12 | 51.86 |
| Support Level | $40.94 | $16.55 |
| Resistance Level | $44.79 | $17.37 |
| Average True Range (ATR) | 1.19 | 0.68 |
| MACD | -0.09 | -0.09 |
| Stochastic Oscillator | 30.78 | 45.68 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.